October 06, 2016
Life Science Research Division to be sold, guidance adjusted accordingly;
Revenues up 8.4% to EUR 373.1m;
Adjusted EBITDA increased by 24.2% to EUR 84.4m;
September 12, 2016
Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners
July 07, 2016
Revenues up 4.0% to EUR 370.5m
Adjusted EBITDA rises 17.5% to EUR 84.7m
Adjusted EBITDA margin climbs to 22.8%
Adjusted earnings per share surpass...
April 28, 2016
Dividend increased to EUR 0.85 per share
Large majorities for resolution approving work of Management Board and Supervisory Board
April 13, 2016
First quarter revenues up 13.4% to EUR 342.3m
Adjusted EBITDA grows by 29.6% to EUR 66.0m (Q1 2015: EUR 51.0m)
Adjusted earnings per share surpasses prior...
February 11, 2016
Revenues in financial year 2015 up 6.8% to EUR 1,377.2m
Adjusted EBITDA climbs to EUR 277.9m
Adjusted earnings per share rise 18.0% to EUR 3.41
November 20, 2015
Duesseldorf, November 20, 2015 - Today Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, informed Dr. Axel Herberg, Chairman of the Supervisory Board of...
November 10, 2015
Issue substantially oversubscribed, allowing increase in initial amount from EUR 250m to finally EUR 425m
Funds used to pay back bridge loan for September...
October 07, 2015
Revenues up 6.2% to EUR 344.0m, 3.1% on organic basis
Adjusted EBITDA rises 9.5% to EUR 68.0m
Adjusted net income increases by 28.3% to EUR 29.2m
July 28, 2015
Centor is the clear market leader in the US prescription plastic vial retail market for oral drugs
The deal extends Gerresheimer’s footprint in the primary...